Key result
Human-induced pluripotent stem cell-derived cardiomyocytes of cardiac origin showed improved differentiation efficiency but no major functional differences compared to those of fibroblastic origin.
hiPSC-derived cardiomyocytes generated from cardiac-stromal progenitor cells show improved cardiac differentiation efficiency but similar electrophysiological responses to ionic current blockade compared to those from skin fibroblasts.
Answers are grounded in this paper and cite their sources.
CPC-derived hiPSC-CMs may refine arrhythmia models in vitro; leaves open clinical translation and source-specific effects.
Human-induced pluripotent stem cell (hiPSC)‐derived cardiomyocytes are likely to revolutionize electrophysiological approaches to arrhythmias. Recent evidence suggests the somatic cell origin of hiPSCs may influence their differentiation potential. Owing to their cardiomyogenic potential, cardiac-stromal progenitor cells (CPCs) are an interesting cellular source for generation of hiPSC‐derived cardiomyocytes. The effect of ionic current blockade in hiPSC‐derived cardiomyocytes generated from CPCs has not been characterized yet. Human-induced pluripotent stem cell‐derived cardiomyocytes were generated from adult CPCs and skin fibroblasts from the same individuals. The effect of selective ionic current blockade on spontaneously beating hiPSC‐derived cardiomyocytes was assessed using multi-electrode arrays. Cardiac-stromal progenitor cells could be reprogrammed into hiPSCs, then differentiated into hiPSC‐derived cardiomyocytes. Human-induced pluripotent stem cell‐derived cardiomyocytes of cardiac origin showed higher upregulation of cardiac-specific genes compared with those of fibroblastic origin. Human-induced pluripotent stem cell‐derived cardiomyocytes of both somatic cell origins exhibited sensitivity to tetrodotoxin, a blocker of Na+ current (INa), nifedipine, a blocker of L-type Ca2+ current (ICaL), and E4031, a blocker of the rapid component of delayed rectifier K+ current (IKr). Human-induced pluripotent stem cell‐derived cardiomyocytes of cardiac origin exhibited sensitivity to JNJ303, a blocker of the slow component of delayed rectifier K+ current (IKs). In hiPSC‐derived cardiomyocytes of cardiac origin, INa, ICaL, IKr, and IKs were present as tetrodotoxin-, nifedipine-, E4031-, and JNJ303-sensitive currents, respectively. Although cardiac differentiation efficiency was improved in hiPSCs of cardiac vs. non-cardiac origin, no major functional differences were observed between hiPSC‐derived cardiomyocytes of different somatic cell origins. Further studies are warranted to characterize electrophysiological properties of hiPSC‐derived cardiomyocytes generated from CPCs.
No takes yet. Share an insight, caveat, or question.
Altomare et al. (2016) studied this question. hiPSC-derived cardiomyocytes of cardiac origin vs. hiPSC-derived cardiomyocytes of fibroblastic origin was evaluated on Sensitivity to selective ionic current blockade and cardiac differentiation efficiency. Human-induced pluripotent stem cell-derived cardiomyocytes of cardiac origin showed improved differentiation efficiency but no major functional differences compared to those of fibroblastic origin.
Synapse has enriched 10 related papers. Consider them for comparative context: